Related Experiment Videos

beta-Thromboglobulin in acute myocardial infarction

Acta Medica Scandinavica. Supplementum
|January 1, 1980
PubMed

Insights

Plasma beta-thromboglobulin levels correlate with acute myocardial infarction severity. Elevated levels in severe cases and a distinct temporal pattern suggest platelet activation precedes coagulation changes in heart attack patients.

Area of Science:

  • Cardiology
  • Hematology
  • Biochemistry

Background:

  • Acute myocardial infarction (AMI) involves complex pathophysiological processes.
  • Platelet activation is a key component in thrombotic events like AMI.
  • Biomarkers reflecting platelet activation are crucial for understanding AMI progression.

Purpose of the Study:

  • To investigate serial plasma beta-thromboglobulin levels in patients with acute myocardial infarction.
  • To correlate beta-thromboglobulin levels with clinical severity and disease course.
  • To explore the temporal relationship between platelet activation and coagulation/fibrinolysis changes.

Main Methods:

  • Serial measurements of plasma beta-thromboglobulin were performed in 14 AMI patients.
  • Platelet counts were monitored alongside beta-thromboglobulin levels.
  • Clinical severity and course of AMI were assessed for each patient.

Main Results:

  • Initially high plasma beta-thromboglobulin levels were observed in 7 patients, correlating with disease severity.
  • Patients with mild/moderate AMI had normal levels throughout.
  • A distinct pattern of initial elevation, followed by a fall and subsequent increase (often peaking at discharge) was noted.
  • Platelet counts exhibited a similar pattern to beta-thromboglobulin.
  • Evidence of platelet activation preceded alterations in coagulation and fibrinolysis.

Conclusions:

  • Plasma beta-thromboglobulin is a sensitive marker for platelet activation in AMI.
  • Elevated levels and specific temporal patterns indicate increased platelet involvement in severe myocardial infarction.
  • Platelet activation appears to be an early event in the pathophysiology of AMI, preceding systemic coagulation and fibrinolysis changes.

Related Concept Videos